NEAT1 and neoplasm: ROC analysis revealed that NEAT1 can be an excellent prognostic biomarker for the Isfahan gastric cancer patient and can be a novel factor for distinguishing the tumor samples from control samples (AUC: 0.924, p-value < 0.0001, Fig. 5b).